Pulmonary Outcomes on Patients With Lung Fibrosis
Not Applicable
Active, not recruiting
- Conditions
- Lung Fibrosis
- Registration Number
- NCT07088185
- Lead Sponsor
- South Valley University
- Brief Summary
The pulmonary fibrosis is lung disease that occurs when lung tissue become damaged and scarred. The objectives of treatment are to improve symptoms and quality of life, and slow disease progression.
- Detailed Description
This study will include 60 patients with pulmonary fibrosis from both gender who are aged from 35 - 55 years old.This study will be randomized controlled trial.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- both gender.
- patients with cystic fibrosis.
Exclusion Criteria
- severe chronic disorders.
- heart failure
- respiratory failure.
- age less than 35 or older than 55 years old.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method FVC One month Forced vital capacity (FVC).
FEV1 One month Forced expiratory volume in the first second (FEV1)
The FEV1 on FVC One month. The ratio between FEV1 and FVC
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
South valley university
🇪🇬Qina, Egypt
South valley university🇪🇬Qina, Egypt